Skip to main content
AVIR
NASDAQ Life Sciences

Phase 3 Hepatitis C Trial Enrollment Complete for Atea Pharmaceuticals

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$4.51
Mkt Cap
$358.521M
52W Low
$2.78
52W High
$6.45
52W Position info
62% above low
Off High info
30% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

AVIR sits 62% above its 52-week low of $2.78.

Summary

Atea Pharmaceuticals has completed patient enrollment for its Phase 3 C-FORWARD trial, evaluating bemnifosbuvir and ruzasvir for Hepatitis C. This trial enrolled over 880 patients outside North America, marking a significant operational milestone for the company's lead antiviral program. This follows positive Phase 1 results for the same regimen announced in late May, continuing the positive news flow. Topline results from the C-FORWARD trial are expected around year-end 2026, with results from the North American C-BEYOND trial anticipated mid-year 2026.

At the time of this announcement, AVIR was trading at $4.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $358.5M. The 52-week trading range was $2.78 to $6.45. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

AVIR - Latest Insights

AVIR
Nov 09, 2026, 5:01 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.41
Real-time Price: $4.49 info
Change: +$0.0801 (+2%) info
Market Cap: $353.703M info
AVIR
Nov 09, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.41
Real-time Price: $4.49 info
Change: +$0.0801 (+2%) info
Market Cap: $353.703M info
AVIR
Nov 09, 2026, 7:30 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.39
Real-time Price: $4.49 info
Change: +$0.1001 (+2%) info
Market Cap: $353.703M info
AVIR
Aug 12, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.06
Real-time Price: $4.49 info
Change: -$0.5699 (-11%) info
Market Cap: $353.703M info
AVIR
Jul 28, 2026, 7:41 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $4.87
Real-time Price: $4.49 info
Change: -$0.3799 (-8%) info
Market Cap: $353.703M info